Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature

Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature

Background: Combination therapy with 5 alpha-reductase inhibitor (5-ARI) and alpha-blocker can be considered as a gold standard intervention for medical management of lower urinary tract symptoms related to benign prostatic hyperplasia (LUTS/BPH). On the other hand, 5-ARI monotherapy and in particu...

Full description

Bibliographic Details
Main Authors: Gian Maria Busetto, Francesco Del Giudice, Daniele D'Agostino, Daniele Romagnoli, Andrea Minervini, Bernardo Rocco, Alessandro Antonelli, Antonio Celia, Riccardo Schiavina, Luca Cindolo, Benjamin I. Chung, Jae Heon Kim, Martina Maggi, Alessandro Sciarra, Ettore De Berardinis, Angelo Porreca
Format: Article
Language:English
Published: PAGEPress Publications 2020-01-01
Series:Archivio Italiano di Urologia e Andrologia
Subjects:
Benign prostatic hyperplasia
5 alpha-reductase inhibitor
Finasteride
Side effects
Online Access:https://pagepressjournals.org/index.php/aiua/article/view/8711

Internet

https://pagepressjournals.org/index.php/aiua/article/view/8711

Similar Items